Sustained Efficacy of Depemokimab Over Time in Type 2 Asthma Characterized by Blood Eosinophils: Pooled Data From the Phase III SWIFT-1/2 Studies

Authors: M.E. Wechsler, R.A. Panettieri, D. Muccino, R. Forth, J. Kwiatek, A. Vichiendilokkul, D.J. Jackson

Published: 2025-05-11

DOI: 10.1164/ajrccm.2025.211.abstracts.a5028

Source: Full article

---

Abstract

No abstract found.